Gain insight into research trends and influential papers with Research Intelligence.
doi.org/10.1016/j.dld.2017.01.056

The immunomodulatory activity of SerpinB3 an protease-inhibitor in vivo and in vitro

..., Patrizia Pontisso
37
Digestive and Liver Disease4.50
Volume: 49, Issue: 1, Pages: e26 - e26
Published: Feb 1, 2017
Abstract
Introduction: NASH is associated with a higher risk of overall mortality and HCC development. The serin protease inhibitor SerpinB3 is not expressed in normal liver, but its level increases in relation with the extent of liver damage. To date, only few data are available on this serpin in the setting of...
Paper Fields
Paper Details
Title
The immunomodulatory activity of SerpinB3 an protease-inhibitor in vivo and in vitro
DOI
doi.org/10.1016/j.dld.2017.01.056
Published Date
Feb 1, 2017
Journal
Digestive and Liver Disease
Volume
49
Issue
1
Pages
e26 - e26
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.